Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
1-Year real-world outcomes of faricimab in previously treated neovascular age-related macular degeneration
Imran Karim Janmohamed
Adeel Mushtaq
Jamil Kabbani
Simeon Harrow
Aaruran Nadarajasundaram
Anibe Ata
Henrietta Monye
Zakariya Jarrar
Shabeeba Hannan
Luke Membrey
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41433-025-03616-5
Jan 25, 2025
Version published to 10.21203/rs.3.rs-5210027/v1 on Research Square
Oct 25, 2024
Related articles
Long-Term Observational Data on Neovascular Age-related Macular Degeneration: A 10-Year Follow-up Study
This article has 4 authors:
Feyza Cukurova
Belgin İzgi
Zafer Cebeci
Nur Kır
OCT Macular Changes in Type 1 ROP following Ranibizumab Injections
This article has 6 authors:
Rawan Hosny
Jylan Gouda
Tamer A Macky
Ayman Khattab
Hany Mekkawy
Abdussalam Mohsen Abdullatif
Clinical care and therapeutic practice of patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) and effectiveness of faricimab in treatment-naive patients in Germany - ZEUS research project
This article has 8 authors:
Albert J Augustin
Finn Fabian Theine
Hakan Kaymak
Julia Clauß
Thilo Schimitzek
Max Zortel
Sandra Bluemich
Astrid Sader-Moritz
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up